Overview

Preemptive Analgesia for Primary Dysmenorrhoea

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
0
Participant gender:
Female
Summary
Preemptive analgesia before the release of pain mediators
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hanan Nabil
Treatments:
Mefenamic Acid
Criteria
Inclusion Criteria:

- nulliparous ladies

- with regular menstrual cycle pattern

- those experienced history of dysmenorrhea (primary or spasmodic)

- patients able to sallow tables

Exclusion Criteria:

- irregular cycles

- any associated local causes( pelvic infection, endometriosis, fibroid or others)

- patients with familial Mediterranean fever or other intermenstrual attacks of
abdominal pain

- gastric or duodenal ulcers or gastritis

- other contraindications to non steroidal anti-inflammatory drugs

- patients with severe diminution of vision or color discrimination

- patients with any depressive or mood disorders

- patients receiving any hormonal treatment